Taxane versus vinorelbine in combination with trastuzumab and pertuzumab for first-line treatment of metastatic HER2-positive breast cancer: a retrospective two-center study-Reference-Cited by-同舟云学术

Taxane versus vinorelbine in combination with trastuzumab and pertuzumab for first-line treatment of metastatic HER2-positive breast cancer: a retrospective two-center study

Published:2021-03-27 Issue: Volume: Page:
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Reinhorn Daniel^ORCID,Kuchuk Iryna,Shochat Tzippy,Nisenbaum Bella,Sulkes Aaron,Hendler Daniel,Rotem Ofer,Tsoref Daliah,Olitzky Olga,Goldvaser Hadar,Sarfaty Michal,Neiman Victoria,Prus Judit,Gottfried Maya,Yust-Katz Shlomit,Yerushalmi Rinat

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-021-06198-4.pdf

Reference23 articles.

1. Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7–34. https://doi.org/10.3322/caac.21551

2. Howlader N, Altekruse SF, Li CI et al (2014) US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst. https://doi.org/10.1093/jnci/dju055

3. Ross JS, Slodkowska EA, Symmans WF et al (2009) The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine. Oncologist 14:320–368. https://doi.org/10.1634/theoncologist.2008-0230

4. Gradishar WJ, Abraham J, Aft R et al (2019) NCCN Guidelines Version 1.2019 Breast Cancer NCCN Guidelines

5. Swain SM, Baselga J, Kim S-B et al (2015) Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. N Engl J Med 372:724–734. https://doi.org/10.1056/NEJMoa1413513

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A clinical systematic literature review of treatments among patients with advanced and/or metastatic human epidermal growth factor receptor 2 positive breast cancer;Journal of Comparative Effectiveness Research;2024-06

2. Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer: a real-world retrospective study in China;Frontiers in Oncology;2023-06-19

3. Breaking the Bottleneck in Anticancer Drug Development: Efficient Utilization of Synthetic Biology;Molecules;2022-11-02

4. Use of peroral form of vinorelbine in metastatic breast cancer – choice in favor of quality of life;Medical alphabet;2022-07-26